Skip to main navigation Skip to search Skip to main content

Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection

Research output: Contribution to journalArticlepeer-review

Abstract

Undifferentiated embryonal sarcoma is the third most common malignant tumor of the liver in children, accounting for 13% of hepatic malignancies in this age group. It has been considered an aggressive neoplasm with very poor prognosis until the late 1980s, when long-term survivors were reported after multiagent chemotherapy followed by resection. We, herein, report two pediatric cases of undifferentiated embryonal sarcoma treated successfully with surgical resection after neoadjuvant chemotherapy based on therapy used in childhood soft tissue sarcomas and in childhood hepatic malignancies. The first patient also had a concurrent cerebellar tumor (pilocytic astrocytoma), for which he first underwent craniotomy and resection, delaying the liver tumor resection by 10 weeks. They are alive and tumor free at 48 months (case no. 1) and 18 months (case no. 2) following neoadjuvant chemotherapy and liver resection. © The Society for Surgery of the Alimentary Tract 2007.
Original languageEnglish
Pages (from-to)73-75
Number of pages3
JournalJournal of Gastrointestinal Surgery
Volume11
Issue number1
DOIs
StatePublished - Jan 2007

ASJC Scopus Subject Areas

  • Surgery
  • Gastroenterology

Keywords

  • Cerebellar tumor
  • Chemotherapy
  • Liver resection
  • Malignant liver tumor
  • Humans
  • Sarcoma/drug therapy
  • Male
  • Combined Modality Therapy
  • Hepatectomy
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Adolescent
  • Liver Neoplasms/drug therapy
  • Neoadjuvant Therapy
  • Child

Cite this